Literature DB >> 844163

Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay.

J Zapf, U Kaufmann, E J Eigenmann, E R Froesch.   

Abstract

We describe a sensitive protein-binding assay for non-suppressible insulin-like activity in human serum. It can detect as little as 0.2 microunits (corresponding to 0.5 ng) of the activity in 0.4 ml of the assay mixture. It is measured in a low-molecular-weight fraction (termed "biological material") obtained by chromatography of serum on Sephadex G-50 in 1 mol/liter acetic acid. This fraction has been shown earlier to contain nearly all this billogically active material that is present in serum. A partially purified carrier protein from human serum is used as the binding protein; different concentrations of a partially purified preparation of material with the activity serve as standards, which compete with 125l-labeled tracer for binding. Biological material dilutes more or less in parallel with the standard over a 10-fold concentration range. In the chromatographed serum fractions, displacing activity appears between 50 and 80% bed volume, with the peak at 60%, and coincides with the distribution and the peak of radioactivity obtained by chromatography of tracer. A good correlation (r = 0.88) is observed between the values determined for this activity in the rat fat-pad assay and the protein-binding assay, although the latter yields about two fold higher results (190 +/- 37 milliunits/liter vs. 345+- 65 milliunits/liter, mean values for 18 normal sera). Values determined in the protein-binding assay are decreased in hypopituitary patients (183 +/- 27 milliunits/liter) and increased in acromegalics (486 +/- 88 milliunits/liter), in accord with the results of the bioassay (68 +/- 21 milliunits/liter for hypopituitary patients, 293 +/- 53 for acromegalics).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844163

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.

Authors:  J Zapf; E Schoenle; G Jagars; I Sand; J Grunwald; E R Froesch
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

2.  Dietary components that regulate serum somatomedin-C concentrations in humans.

Authors:  W L Isley; L E Underwood; D R Clemmons
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

3.  NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.

Authors:  C Meuli; J Zapf; E R Froesch
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

4.  Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.

Authors:  A C Herington; A D Kuffer
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

5.  Alveolar macrophages release an insulin-like growth factor I-type molecule.

Authors:  W N Rom; P Basset; G A Fells; T Nukiwa; B C Trapnell; R G Crysal
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

Authors:  J Zapf; E Futo; M Peter; E R Froesch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Developmental pattern of a serum binding protein for multiplication stimulating activity in the rat.

Authors:  R M White; S P Nissley; P A Short; M M Rechler; I Fennoy
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.